• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • Video Database
  • About Us
  • EN
    • HU
    • RU

Critical Partners: The Role of Civil Society in Drug Policies in Four EU Countries

February 13, 2024 | Author: Péter Sárosi

Tweet

This report gives an insight into how governments involve civil society in drug policy decision-making in four European countries.

Our focus group study, conducted by the Correlation European Harm Reduction Network in cooperation with the Rights Reporter Foundation in four countries (Finland, Hungary, Greece and Ireland), attempts to look behind the facade of official structures and mechanisms of civil society involvement. We assessed the perceptions of civil society actors and decision-makers about how meaningful they find their partnerships.

Please read the report here!

A presentation about the report (video):

Civil society is a critical partner in policy-making. Decision-makers must work with civil society in developing and implementing policies. Civil society organisations and activists work closely with affected communities and have extensive on-the-ground experience incremental to make policies reality-based and effective. Civil society is also a critical voice because it is part of the mission of a vibrant civil society to be critical of all-time power. As the so-called “third sector,” civil society is a counterbalance to the government and the market. Ideally, civil society organisations partner with governments without giving up their independence to express their criticisms of government policies publicly.

In theory, this all sounds great. However, in actual criticisms of real policies, the conflicting understandings of the role of civil society often generate conflicts. When civil society organisations make positions and express their critical opinion about laws and policies, they are often seen by governments as political actors.   

Some of the main findings of the report:

  • Some mechanisms to involve civil society in national drug policies exist in all four countries but they vary greatly in many aspects.
  • Despite the existence of formal mechanisms, most participants of civil society FGDs claimed that the most meaningful dialogue happens through informal channels.
  • There was a significant difference between the perception of the meaningfulness of civil society
    involvement between decision makers and civil society.
  • The transparency and accountability of decision making in the drug field was perceived as low by most civil society representatives in all four countries.
  • It was recognised by both decision makers and civil society in all countries that the selection of CSOs who are engaged is sometimes not balanced and inclusive.
  • In most countries, both decision makers and civil society found that there is sufficient time given to civil society to express its views about proposed new policies and laws.
  • In most countries, government officials are seen as approachable by civil society.
  • There was a general perception in all countries that civil society representatives are highly competent in their professional knowledge of the field in which they work but this competence is limited when it comes to policy making.
  • Decision makers often see civil society overstepping its role by making statements about policies. Civil society often sees this attitue as a violatation its autonomy.
  • This research identified a perceived trend in most countries that can be called the shrinking space for civil society: organisations and activists feel that they are increasingly excluded, marginalised and scapegoated for being critical.
  • The work of civil society representatives as consultants in civil society involvement mechanisms is not paid in any of the assessed countries.
  • One of the key findings of this research is that despite existing formal mechanisms, and despite the openly declared support and recognition of civil society involvement by civil servants, all civil society representatives participating in the FGDs expressed their frustration about being unable to make a meaningful impact in policy making.


Categories: ArticlesArchives: Activism, Drug Policy and Law, European Drug Policy, Harm ReductionCountry: Finland, Greece, Hungary, Ireland

Related articles:

In the UN, the Direction of Drug Policy Can Be Determined by Whether a Single Word Remains in the Text or Not

April 22, 2026 - Péter Sárosi

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

April 20, 2026 - István Gábor Takács

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh

April 17, 2026 - István Gábor Takács

Related videos:

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

April 20, 2026 - István Gábor Takács

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh

April 17, 2026 - István Gábor Takács

Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

Dismantling Orbán’s System – Drugreporter interviewed by Arild Knutsen

April 10, 2026 - Arild Knutsen

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Checking Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!

Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter | Prémium WordPress